Statistics for Bivalent Ligand MMG22 Reduces Bone Cancer Pain without Tolerance or Sedation

Total visits

views
Bivalent Ligand MMG22 Reduces Bone Cancer Pain without Tolerance or Sedation 39

Total visits per month

views
August 2024 0
September 2024 0
October 2024 0
November 2024 1
December 2024 0
January 2025 2
February 2025 0

File Visits

views
Shueb_umn_0130E_23594.pdf 53

Top country views

views
United States 15
United Kingdom 4
Taiwan 3
Canada 2
Ireland 2
Switzerland 1
China 1
Germany 1
Egypt 1
Hong Kong SAR China 1
Indonesia 1
India 1
Netherlands 1
Russia 1
Turkey 1
Ukraine 1

Top city views

views
Chicago 2
Dublin 2
Minneapolis 2
Amsterdam 1
Ankara 1
Ashburn 1
Blacksburg 1
Camberley 1
Central 1
Chang-hua 1
Chaska 1
Daettlikon 1
Ipswich 1
Jakarta 1
Knoxville 1
London 1
Ludhiana 1
Mountain View 1
Rothenbach an der Pegnitz 1
St Louis 1
Taichung 1
Valley Stream 1
Vladivostok 1
Windsor 1